Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice

Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice

Abstract Background This nationwide study assessed the impact of nationally agreed cancer genetics guidelines on use of BRCA1/2 germline testing, risk management advice given by health professionals to women with pathogenic BRCA1/2 variants and uptake of such advice by patients. Methods Clinic files...

Full description

Bibliographic Details
Main Authors: Bettina Meiser, Rajneesh Kaur, April Morrow, Michelle Peate, W. K. Tim Wong, Emily McPike, Elisa Cops, Cassandra Nichols, Rachel Austin, Miriam Fine, Letitia Thrupp, Robyn Ward, Finlay Macrae, Janet E. Hiller, Alison H. Trainer, Gillian Mitchell, for the ICCon Audit Study Collaborative Group
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
Guidelines
Compliance
Genetic testing
Cancer risk
BRCA1 and BRCA2
Online Access:https://doi.org/10.1186/s13053-021-00180-3

Internet

https://doi.org/10.1186/s13053-021-00180-3

Similar Items